707
Views
12
CrossRef citations to date
0
Altmetric
Themed Reviews

Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications

, &
Pages 357-367 | Received 26 May 2010, Accepted 13 Oct 2010, Published online: 27 Mar 2011

References

  • Agarwal A, Halvorson LM, Legradi G. 2005. Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res. 138:45–57.
  • Al-Gahtany M, Horvath E, Kovacs K. 2003. Pituitary hyperplasia. Hormones (Athens). 2:149–158.
  • Auernhammer CJ, Bousquet C, Melmed S. 1999. Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA. 96:6964–6969.
  • Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R. 2004. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem. 279:1422–1428.
  • Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. 1989. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242:237–239.
  • Cheng YH, Nicholson RC, King B, Chan EC, Fitter JT, Smith R. 2000. Glucocorticoid stimulation of corticotropin-releasing hormone gene expression requires a cyclic adenosine 3′,5′-monophosphate regulatory element in human primary placental cytotrophoblast cells. J Clin Endocrinol Metab. 85:1937–1945.
  • Childs GV, Rougeau D, Unabia G. 1995. Corticotropin-releasing hormone and epidermal growth factor: Mitogens for anterior pituitary corticotropes. Endocrinology. 136:1595–1602.
  • Foulkes NS, Borrelli E, Sassone-Corsi P. 1991. CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell. 64:739–749.
  • Fukuda Y, Kageyama K, Nigawara T, Kasagi Y, Suda T. 2004. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: A study using CRH-deficient mice. Neurosci Lett. 367:201–204.
  • Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, Murphy D. 2003. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem. 278:19280–19285.
  • Gillies GE, Linton EA, Lowry PJ. 1982. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 299:355–357.
  • Grinevich V, Fournier A, Pelletier G. 1997. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res. 773:190–196.
  • Guardiola-Diaz HM, Kolinske JS, Gates LH, Seasholtz AF. 1996. Negative glucocorticoid regulation of cyclic adenosine 3′,5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol Endocrinol. 10:317–329.
  • Jacobson L, Sharp FR, Dallman MF. 1990. Induction of fos-like immunoreactivity in hypothalamic corticotropin-releasing factor neurons after adrenalectomy in the rat. Endocrinology. 126:1709–1719.
  • Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T. 2007. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin, and interleukin-6 gene transcription in hypothalamic 4B cells. J Encocrinol. 195:199–211.
  • Kageyama K, Hanada K, Takayasu S, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T. 2008. Involvement of regulatory elements on corticotropin-releasing factor gene promoter in hypothalamic 4B cells. J Endocrinol Invest. 31:1079–1085.
  • Kageyama K, Hanada K, Iwasaki Y, Suda T. Regulation and role of suppressor of cytokine signaling-3 in hypothalamic 4B cells. J Endocrinol. 2009a; 201:369–376.
  • Kageyama K, Sakihara S, Suda T. Regulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary. Regul Pept. 2009b; 152:88–94.
  • Kageyama K, Akimoto K, Suda T. 2010. Corticotropin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. J Neuroendocrinol. 22:971–978.
  • Karagianni N, Tsawdaroglou N. 1994. The c-fos serum response element (SRE) confers negative response to glucocorticoids. Oncogene. 9:2327–2334.
  • Karalis K, Muglia LJ, Bae D, Hilderbrand JA. 1997. CRH and the immune system. J Neuroimmunol. 72:131–136.
  • King BR, Smith R, Nicholson RC. 2002. Novel glucocorticoid and cAMP interactions on the CRH gene promoter. Mol Cell Endocrinol. 194:19–28.
  • Knaus UG, Morris S, Dong HJ, Chernoff J, Bokoch GM. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science. 269:221–223.
  • Krebs DL, Hilton DJ. 2000. SOCS: Physiological suppressors of cytokine signaling. J Cell Sci. 113:2813–2819.
  • Lalli E, Sassone-Corsi P. 1994. Signal transduction and gene regulation: The nuclear response to cAMP. J Biol Chem. 269:17359–17362.
  • Legradi G, Holzer D, Kapcala LP, Lechan RM. 1997. Glucocorticoids inhibit stress-induced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology. 66:86–97.
  • Ma XM, Aguilera G. 1999. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology. 140:5642–5650.
  • Malkoski SP, Dorin RI. 1999. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Endocrinol. 13:1629–1644.
  • Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, Leung T, Lim L. 1997. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol. 17:1129–1143.
  • McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly SP, Kozlowski MR, Neve KA, Neve RL. 2003. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J Neurosci. 23:6914–6927.
  • Melzig MF, Papsdorf G, Loose R, Winkler A, Beyermann M, Krause E, Zipper J. 1998. Effects of long-term treatment with corticotropin-releasing factor on corticotropic tumor cells in vitro. Regul Pept. 74:35–40.
  • Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 164:567–574.
  • Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P. 1993. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor. Cell. 75:875–886.
  • Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Andoh N, Ohtani H, Masuda T, Sasano N. 1993. Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology. 57:34–39.
  • Muglia LJ, Jenkins NA, Gilbert DJ, Copeland NG, Majzoub JA. 1994. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin Invest. 93:2066–2072.
  • Muglia L, Jacobson L, Dikkes P, Majzoub JA. 1995. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:427–432.
  • Muglia LJ, Jacobson L, Weninger SC, Luedke CE, Bae DS, Jeong KH, Majzoub JA. 1997. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J Clin Invest. 99:2923–2929.
  • Muglia LJ, Jacobson L, Luedke C, Vogt SK, Schaefer ML, Dikkes P, Fukuda S, Sakai Y, Suda T, Majzoub JA. 2000. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest. 105:1269–1277.
  • Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. 1991. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 128:37–44.
  • Nomura M, Ueta Y, Serino R, Kabashima N, Shibuya I, Yamashita H. 1996. PACAP type I receptor gene expression in the paraventricular and supraoptic nuclei of rats. Neuroreport. 8:67–70.
  • Ochedalski T, Subburaju S, Wynn PC, Aguilera G. 2007. Interaction between oestrogen and oxytocin on hypothalamic–pituitary–adrenal axis activity. J Neuroendocrinol. 19:189–197.
  • Ogura E, Kageyama K, Hanada K, Kasckow J, Suda T. 2008. Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type beta in hypothalamic 4B cells. Peptides. 29:456–464.
  • Ram PA, Waxman DJ. 1999. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem. 274:35553–35561.
  • Schimpl A, Wecker E. 1972. Replacement of T-cell function by a T-cell product. Nat New Biol. 237:15–17.
  • Schmitz J, Weissenbach M, Haan S, Heinrich PC, Schaper F. 2000. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem. 275:12848–12856.
  • Seasholtz AF, Thompson RC, Douglass JO. 1988. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol. 2:1311–1319.
  • Shioda S, Shuto Y, Somogyvari-Vigh A, Legradi G, Onda H, Coy DH, Nakajo S, Arimura A. 1997. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci Res. 28:345–354.
  • Spengler D, Rupprecht R, Van LP, Holsboer F. 1992. Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol. 6:1931–1941.
  • Suda T, Tozawa F, Yamaguchi H, Shibasaki T, Demura H, Shizume K. 1982. Multiple forms of immunoreactive ß-endorphin are present in an ectopic adrenocorticotropin-producing tumor but not in normal pituitary or pituitary adenomas. J Clin Endocrinol Metab. 54:167–171.
  • Suda T, Yajima F, Tomori N, Demura H, Shizume K. 1985. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. Life Sci. 37:1499–1505.
  • Suda T, Kondo M, Totani R, Hashimoto N, Suzuki M, Imaki T, Oba Y, Tomori N, Tozawa F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K. 1986. Ectopic adrenocorticotropin syndrome caused by lung cancer that responded to corticotropin-releasing hormone. J Clin Endocrinol Metab. 63:1047–1051.
  • Takaki A, Huang QH, Somogyvari-Vigh A, Arimura A. 1994. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation. 1:335–342.
  • Turnbull AV, Rivier CL. 1999. Regulation of the hypothalamic–pituitary–adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev. 79:1–71.
  • Vale W, Spiess J, Rivier C, Rivier J. 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1394–1397.
  • Vallieres L, Rivest S. 1999. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology. 140:3890–3903.
  • van der Laan S, Lachize SB, Vreugdenhil E, de Kloet ER, Meijer OC. 2008. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene. Endocrinology. 149:725–732.
  • van Wijk PA, van Neck JW, Rijnberk A, Croughs RJ, Mol JA. 1995. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Mol Cell Endocrinol. 111:13–19.
  • Venihaki M, Dikkes P, Carrigan A, Karalis KP. 2001. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest. 108:1159–1166.
  • Yamamori E, Asai M, Yoshida M, Takano K, Itoi K, Oiso Y, Iwasaki Y. 2004. Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells. J Mol Endocrinol. 33:639–649.
  • Yao M, Denver RJ. 2007. Regulation of vertebrate corticotropin-releasing factor genes. Gen Comp Endocrinol. 153:200–216.
  • Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM. 1995. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem. 270:23934–23936.
  • Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. 1993. Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic–pituitary–adrenal axis. Endocrinology. 133:2523–2530.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.